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about one quarter of ambulance crews in London are
paramedics, but analysis of workload suggests that less than
one tenth of calls require paramedical skills. The London
Ambulance Service already trains more paramedics than any
other service in Britain and loses some of them to provincial
services after training.
Only one third of hospitals served by the London Ambu-
lance Service provide clinical training placements for para-
medics, and even to meet current needs this will require a
substantial increase. To achieve the Department of Health's
target will require a substantial increase in training at
considerable cost. Is this likely to be economic? How will
most paramedics maintain their skills when only a small
proportion of calls require them?'0 Will the damage to the
morale of staff who are not paramedics, seen in other services
with the development of an elite, occur in London? The
London Ambulance Service has avoided many of these
problems by ensuring that some extended skills, such as
provision of defibrillation and nebuliser treatment, are taught
to every qualified ambulance person. Evidence also exists that
ambulance staff who are not paramedics can safely identify
and treat hypoglycaemia with glucagon." If implementing a
dispatch system responsive to medical priority shows that
resources are being effectively targeted according to clinical
need the aim of having a paramedic in every front line vehicle
would need to be reconsidered.
Historically, informal links with individual clinicians and
specialty groups have facilitated many changes in ambulance
training, operations, and equipment. As the range and
complexity of prehospital care increases, however, the
mechanisms for medical input to the London Ambulance
Service and the audit ofoutcomes will need review. Currently,
there is official medical input to extended training in the form
of the paramedic steering committee as required by the NHS
Training Directorate, but in other matters of policy the only
other medical forum, the medical advisory group, has no
operational responsibilities. Recent initiatives that have
required close liaison are the development of joint training for
ambulance and medical incident officers in the management
of major incidents,'2 proposals for increasing direct com-
munication between ambulances and accident and emergency
departments, and the development of alternatives to obstetric
flying squads.'3 The input of the medical advisory group to
long term planning and development would be valuable.
Unified medical input and systematic audit'4 are particularly
necessary in view of the differing medical opinions and
prejudices regarding the philosophies of "scoop and run"
versus "treat in the street." How best to coordinate medical
advice for the London Ambulance Service should be a matter
for debate. In particular, the potential benefit to London of
the consultant medical director model-popular in the United
States and currently being pioneered in the Scottish Ambu-
lance Service-will need careful assessment.
Public interest in the London Ambulance Service is
obvious, but public confidence, shaken by the 1989 ambulance
strike and by the problems of last year, needs to be restored.
Although response times have the highest profile-being
easily measured-the quality of clinical care delivered is also
crucially important, and its absence from the topics included
in the service's annual corporate review is regrettable.15
The London Ambulance Service's new management must
make an unequivocal commitment to both basic and extended
training and the establishment of systematic clinical audit to
build on the progress made to date. As a consumer, the public
has a part to play in making the service more efficient, and a
health education campaign supported by the government is
long overdue. Management commitment is likely to produce
better response times over the next three years, but this will be
a hollow achievement without advances in clinical care.
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Measuring patients' views: the optimum outcome measure
SF 36: a valid, reliable assessment ofhealthfrom the patient's point ofview
The debate about whether and how to measure medical
outcomes is heating up as those who fund medical care put
providers under greater pressure to control their costs. With
little known about which features of medical services improve
outcomes, policies that reduce costs will be deemed successful
unless data on outcomes show otherwise. Hence the need to
study outcomes.
The ideal outcome of treatment is a return to the normal or
usual quality of life for a given age and medical condition.'
Since the first health interview surveys of sickness and
disability, the hunt has been on for a reliable measure of how
people perceive their health.2 Great strides have recently been
made in standardising self reported measures of functioning
and wellbeing and using them to monitor outcomes. With the
standardised self report survey emerging as the best method
of measuring outcomes from the patient's point of view, now
is a good time to take stock of these advances.
To date the evaluation of such surveys has mainly been
controlled by the researchers who developed them, but health
care policy makers, clinical investigators, and providers
should now get involved. The contributions ofJenkinson and
colleagues (p 1437)3 and Garratt and colleagues (p 1440)4 in
this week's journal and an earlier contribution by Brazier et al
provide useful information about the performance of the
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American short form (SF 36) health survey questionnaire
adapted for British use. These papers show the ease of
administering this self report survey, and suggest that other
English speaking countries such as Australia and Canada may
be able to use it with minimal changes.
These papers also show the value of two different strategies
for interpreting health status-approaches based on norms
and criteria.34 Norms allow individual scores and group
averages to be interpreted according to where they lie in the
distribution of scores for a general population. They are
particularly useful when no single criterion or "gold standard"
for evaluating health exists. Because men and women of
different ages report different levels of health, separate norms
can be calculated for these groups and for different occupa-
tional groups.3 These norms will greatly help to estimate the
burden of specific conditions. The inclusion of criterion
variables such as medical conditions, severity of illness, and
use of health care services is useful in interpreting the
surveys.6'78
Garratt and colleagues show that SF 36 scores tend to
correlate with doctors' assessment of the severity of illness,
which is encouraging. But this holds true only on average:
functioning and wellbeing vary greatly even among patients
with the same condition.67 Some of this variation may be due
to treatment and to factors that change over time. Follow
up studies planned by Garratt and colleagues and more
widespread use of self report measures in clinical trials should
improve our understanding ofwhy outcomes vary and how to
improve them.
After extensive evaluations of the content of the SF 36, it is
encouraging that these investigations conclude that only
minor changes in six items were required to adapt the SF 36
for British use.3-5 For example, "walking one block" was
changed to "walking 100 yards" and "full of pep" was
changed to "full of life." These changes are unlikely to affect
the reliability and validity of the scores. When it comes
to the grouping of items and tests of scoring assumptions
British research seems to replicate the findings of American
research.68-10 Given the overall consistency of the British
and American results, other findings in one country are likely
to zeneralise to the other.8
Although simple and brief self report surveys risk a loss of
precision and comprehensiveness, studies suggest that
the substantial reduction in the burden they placed on
respondents is accompanied by only a small drop in pre-
cision."' In clinical practice, however, where decisions are
based on assessments of individual patients, even a small drop
in the reliability of the score greatly increases the "noise
level": less reliable surveys will require larger changes in
patient scores to register. To guide clinical use, confidence
intervals for the SF 36 scales have therefore been estimated for
individual patients in the United States.8 Another trade off
affects comprehensiveness: short forms require that some
concepts are left out. But, as the authors of the British papers
show, a "core" survey that requires only 5 to 10 minutes to
complete provides ample room for questions to be added.
Whether favourable estimates of reliability and validity
from cross sectional studies will hold true for longitudinal
studies remains to be proved. According to psychometric
theory, measures that discriminate well among different
groups of patients at one particular time tend to do well in
capturing changes over time. Evidence supporting this has
been found for the SF 36.811 Changes in SF 36 scores in one
group over time can usually be measured with greater
precision than differences between two groups.8
To protect the standardisation of the SF 36, ensure
comparability across studies and countries, and assure its
widespread availability without any fee the copyright for
SF 36 and the trademark were placed with the Medical
Outcomes Study Trust, a non-profit making organisation.'2
The trust ensures that the "SF 36" label is used only for
forms and scoring algorithms that are comparable to the
published SF 36 standard. Those who depart from the
standard are required to use a different label so that others
will know that data may not be comparable. An international
team of investigators is currently developing authorised
translations of the SF 36 through the international quality
of life assessment project."3 Sponsors of the project, including
Glaxo and Schering-Plough Research, have agreed to place
all translations with the Medical Outcomes Study Trust
along with the British version ofthe SF 36 described here.3'
There has been considerable debate over the choice
between disease specific and generic measures of outcome in
clinical trials and studies of cost effectiveness, and numerous
research teams funded by the American government are
administering both. In North America the SF 36 is currently
being used in more than 200 clinical trials, where investigators
are interested in the impact of treatment on the quality of life
as well as on more traditional medical outcomes. Measures of
generic and specific outcomes usually prove to be more useful
than either alone.
Much cooperation is needed to define and preserve a
measurement standard and to advance understanding of the
scores. The challenge is greatest when many groups are
involved and funding resources limited. In the United States
development of measures in the medical outcomes study
began with support from philanthropic sources, which have
been joined by several federal agencies.'4 In Britain the
King's Fund has funded studies with the SF 36, including
those by the Public Health Research Centre in Salford, the
Department of Public Health in Nottingham, and the North
West Thames Regional Health Authority. The contributions
by Jenkinson and colleagues and Garratt and colleagues in
this week's journal mark an important step forwards in
monitoring and improving outcomes.
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